Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

被引：0
|
作者：
Alice Indini
Lorenza Di Guardo
Carolina Cimminiello
Michele Prisciandaro
Giovanni Randon
Filippo De Braud
Michele Del Vecchio
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Melanoma Medical Oncology Unit, Department of Medical Oncology and Hematology
[2] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Department of Medical Oncology and Hematology
[3] Fondazione IRCCS Istituto Nazionale dei Tumori di Milano,Università degli studi di Milano
来源：
Journal of Cancer Research and Clinical Oncology | 2019年 / 145卷
关键词：
Melanoma; Immunotherapy; Anti-PD1; IrAEs; Vitiligo; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：511 / 521
页数：10
相关论文
共 50 条
  • [1] Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma
    Indini, Alice
    Di Guardo, Lorenza
    Cimminiello, Carolina
    Prisciandaro, Michele
    Randon, Giovanni
    De Braud, Filippo
    Del Vecchio, Michele
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (02) : 511 - 521
  • [2] Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
    Cortellini, Alessio
    Chiari, Rita
    Ricciuti, Biagio
    Metro, Giulio
    Perrone, Fabiana
    Tiseo, Marcello
    Bersanelli, Melissa
    Bordi, Paola
    Santini, Daniele
    Giusti, Raffaele
    Grassadonia, Antonino
    Di Marino, Pietro
    Tinari, Nicola
    De Tursi, Michele
    Zoratto, Federica
    Veltri, Enzo
    Malorgio, Francesco
    Garufi, Carlo
    Russano, Marco
    Anesi, Cecilia
    Zeppola, Tea
    Filetti, Marco
    Marchetti, Paolo
    Berardi, Rossana
    Rinaldi, Silvia
    Tudini, Marianna
    Silva, Rosa Rita
    Pireddu, Annagrazia
    Atzori, Francesco
    Iacono, Daniela
    Migliorino, Maria Rita
    Porzio, Gampiero
    Cannita, Katia
    Ficorella, Corrado
    Buti, Sebastiano
    CLINICAL LUNG CANCER, 2019, 20 (04) : 237 - +
  • [3] Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
    Pollack, M. H.
    Betof, A.
    Dearden, H.
    Rapazzo, K.
    Valentine, I.
    Brohl, A. S.
    Ancell, K. K.
    Long, G. V.
    Menzies, A. M.
    Eroglu, Z.
    Johnson, D. B.
    Shoushtari, A. N.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 250 - 255
  • [4] Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
    Owen, C. N.
    Bai, X.
    Quah, T.
    Lo, S. N.
    Allayous, C.
    Callaghan, S.
    Martinez-Vila, C.
    Wallace, R.
    Bhave, P.
    Reijers, I. L. M.
    Thompson, N.
    Vanella, V.
    Gerard, C. L.
    Aspeslagh, S.
    Labianca, A.
    Khattak, A.
    Mandala, M.
    Xu, W.
    Neyns, B.
    Michielin, O.
    Blank, C. U.
    Welsh, S. J.
    Haydon, A.
    Sandhu, S.
    Mangana, J.
    McQuade, J. L.
    Ascierto, P. A.
    Zimmer, L.
    Johnson, D. B.
    Arance, A.
    Lorigan, P.
    Lebbe, C.
    Carlino, M. S.
    Sullivan, R. J.
    Long, G., V
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 (07) : 917 - 925
  • [5] Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
    Suo, Aleksi
    Chan, Yin
    Beaulieu, Carissa
    Kong, Shiying
    Cheung, Winson Y.
    Monzon, Jose G.
    Smylie, Michael
    Walker, John
    Morris, Don
    Cheng, Tina
    ONCOLOGIST, 2020, 25 (05): : 438 - 446
  • [6] Correlation between immune-related adverse events and treatment efficacy of anti-PD1 immunotherapy in patients with esophageal squamous cell carcinoma
    Cao, Ruijie
    Wu, Chensi
    Lv, Yalei
    Xu, Shuo
    Li, Cuizhen
    Yin, Fei
    Li, Jing
    ONCOLOGY LETTERS, 2023, 25 (02)
  • [7] Immune-related adverse events in a nationwide cohort of melanoma patients treated with adjuvant anti-PD1: Seasonal variation and association with outcome
    Ellebaek, E.
    Jurlander, R. S.
    Guldbrandt, L. M.
    Holmstroem, R. B.
    Donia, M.
    Haslund, C. A.
    Schmidt, H.
    Bastholt, L.
    Ruhlmann, C. H.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2023, 34 : S690 - S690
  • [8] Immune-related adverse events: Comparison of melanoma and non-small cell lung cancer patients treated with anti-PD1 therapy
    Duma, N.
    Azzouqa, A-G.
    Yadav, S.
    Hoversten, K.
    Reed, C.
    Sitek, A. N.
    Lou, Y.
    Molina, J.
    Halfdanarson, T.
    Leventakos, K.
    Joseph, R. W.
    Manochakian, R.
    Dronca, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 432 - 432
  • [9] Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy
    Ezponda Casajus, A.
    Calvo Imirizaldu, M.
    de Torres Tajes, J. P.
    Garcia-Baizan, A.
    Castanon Alvarez, E.
    Cano Rafart, D.
    Vivas Perez, I
    Bastarrika Aleman, G.
    RADIOLOGIA, 2020, 62 (02): : 131 - 138
  • [10] Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti-CTLA-4 Antibody Therapy
    Bronstein, Yulia
    Ng, Chaan S.
    Hwu, Patrick
    Hwu, Wen-Jen
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (06) : W992 - W1000
12345